April 23, 2018 / 11:40 AM / a month ago

BRIEF-Paladin Labs Announces Launch Of New Indication For Xiaflex, Broadening Its Use To The Treatment Of Appropriate Patients With Peyronie's Disease

April 23 (Reuters) - Endo International PLC:

* PALADIN LABS INC. ANNOUNCES LAUNCH OF NEW INDICATION FOR XIAFLEX® (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM), BROADENING ITS USE TO THE TREATMENT OF APPROPRIATE PATIENTS WITH PEYRONIE’S DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below